Jordan Suchy
Psychiatry · Lakewood, CONPI 1063040855
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,583, more than ten times the $15 reported in 2022. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $21.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$688
- Vanda Pharmaceuticals Inc.$372
- Axsome Therapeutics, Inc.$344
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$333
- Otsuka America Pharmaceutical, Inc.$248
- Alkermes, Inc.$242
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,385100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $688 |
| Vanda Pharmaceuticals Inc. | 18 | $372 |
| Axsome Therapeutics, Inc. | 11 | $344 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $333 |
| Otsuka America Pharmaceutical, Inc. | 15 | $248 |
| Alkermes, Inc. | 10 | $242 |
| Tris Pharma Inc | 5 | $223 |
| Bausch Health US, LLC | 7 | $136 |
| E.r. Squibb & Sons, L.L.C. | 6 | $121 |
| Corium, LLC | 9 | $114 |
| Collegium Pharmaceutical, Inc. | 6 | $104 |
| Vertical Pharmaceuticals, LLC | 5 | $103 |
| Neurocrine Biosciences, Inc. | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $97 |
| Sage Therapeutics, LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Almatica Pharma LLC | 1 | $30 |
| Lundbeck LLC | 1 | $22 |
| Indivior Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$3,385 in reported general payments places this provider in the 90th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 19 | $672 |
| Clonazepam | 31 | $404 |
| Gabapentin | 20 | $400 |
| Lamotrigine | 14 | $215 |
| Escitalopram Oxalate | 13 | $190 |
| Trazodone Hcl | 12 | $93 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Lakewood
- Michael GowerLakewood$6K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
- Robert CowanCentennial$29K
- Brenda CzabanDenver$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.